GlaxoSmithKline, Philadelphia, PA

GlaxoSmithKline

www.gsk.com

We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization`s three priority diseases – HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. Our product portfolio also includes a range of consumer brands, many of which are household names around the world, including Sensodyne, Aquafresh, Horlicks, Panadol and Tums.

Number of Employees: 50K-100K
Annual Revenue: > $1 Billion

www.gsk.com
5 Crescent Drive
Philadelphia, PA USA 19112
Phone: 215.751.7160

Executives

Name	Title	Contact Details
Delfim Martins	VP Cyber Defense	Profile
Lisa Ackerman	Deputy CISO, Cyber Security Strategy and Solutions	Profile
Jeff Wrona	Senior Director, Security Infrastructure, Global Security Operations, GSK	Profile
Tara Jaques	Sr. Director, Security Posture and Assurance	Profile
Jon Frampton	Director, Data Security Services	Profile

Similar Companies

Advanced Clinical Services

Advanced Clinical Services is a Deerfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Purdue Pharma L.P.

Purdue Pharma LP is a privately held pharmaceutical company founded by John Purdue Gray.

Sigma-Tau PharmaSource

Sigma-Tau PharmaSource is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hart Design Group

Hart Design Group is a Cumberland, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company`s lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. The company also has a portfolio of programs, including PIPE-307, focused on remyelination and axonal repair, to address a range of neurological disorders, including multiple sclerosis.